Objective To analyse whether the percentage of free to total prostate‐specific antigen (%fPSA) is a prognostic biomarker in metastatic castration‐resistant prostate cancer (mCRPC), as novel studies suggest an elevated %fPSA is associated with adverse oncological outcomes for men with biochemical recurrence of prostate cancer.
Andrew W. Silagy+13 more
wiley +1 more source
Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data. [PDF]
Fiorica F+12 more
europepmc +1 more source
DOSAGE DE L'HORMONE THYRÉOSTIMULANTE HYPOPHYSAIRE OVINE A L'AIDE D'UN SYSTÈME RADIO-IMMUNOLOGIQUE BOVIN. EFFETS COMPARÉS DE LA THYROÏDECTOMIE ET DE LA CASTRATION SUR LES TAUX DE TSH ET DE LH PLASMATIQUES CHEZ LES OVINS [PDF]
P Freychet+5 more
openalex +1 more source
In the phase 3 PROpel trial (NCT03732820), first‐line treatment with olaparib plus abiraterone significantly prolonged radiographic progression‐free survival (rPFS) and numerically prolonged overall survival (OS) versus placebo plus abiraterone in patients with metastatic castration‐resistant prostate cancer (mCRPC).
Mototsugu Oya+20 more
wiley +1 more source
The prognostic role of systemic immune-inflammation index, SII, in Metastatic Castration-Resistant Prostate Cancer patients. [PDF]
Uzun M, Gokcek S, Kaya E, Semiz HS.
europepmc +1 more source
Animal castration; a book for the use of students and practitioners, by George R. White.
G. R. White
openalex +2 more sources
Fun, flirtation and fear: Selfies in teenage girls digital exchange cultures
Abstract This paper explores teenage girls' engagement with digital images on social media. Using new feminist materialism, we foreground digital images as an assemblage of materialities (human and more‐than‐human) filled with affective potentials that materialise in/capacities.
Raksha Janak+2 more
wiley +1 more source
Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. [PDF]
Castro E+6 more
europepmc +1 more source
Cutting‐Edge Advancements in the Antibiotics‐Gut Microbiota‐Urinary Tumour Axis
Gut microbiota regulates urological tumors. Antibiotics induce dysbiosis, altering tumor progression/therapy: reducing carcinogen metabolism but impairing immunity. Specific bacteria enhance immune responses and combat endocrine resistance. Future research should unravel microbiota‐cancer links and develop microbiome‐targeted therapies to optimize ...
Jie Wang+3 more
wiley +1 more source